Today there’s a new call for clinical trial participants regarding psychiatric meds and pregnancy. MISSD supports improved data collection and transparent communication to improve patient safety.

The trial may uncover important finidings given that research shows that when taken during pregnancy, SSRIS can be associated with an increased risk of congenital heart defects and that up to 30% of exposed newborns may experience withdrawal symptoms after birth. Accurate info can help parents, clinicians, and researchers make better-informed decisions.

For more info, see https://www.medpagetoday.com/clinical-trial-finder/study/nct01246765?category=psychiatry&topic=adhd&xid=nl_mpt_clinicaltrials_psychiatry2025-10-27&mh=b36786d8242d266f4bb652c0dc8afd66&zdee=gAAAAABm4u6co5yqhud2n1bxWGd7sMMIzGODjyi5yiJbiU776UmtHFCJ1kENUJt34LAE9XQZhrz9RcsNavUdU6W-qeehZ2pcj8fzrTXl0-WR5k-uKQbKQrg%3D